Lactobacillus Paracasei for Immune Function

Research suggests that Lactobacillus paracasei may support certain aspects of immune function, with the most consistent evidence coming from studies showing enhanced antibody responses to influenza vaccination, improved natural killer cell activity, and shifts in immune cell populations associated with reduced inflammation — findings supported by several randomized controlled trials and animal or cell-based studies. Studies indicate potential benefits in contexts ranging from respiratory illness duration to gut-related immune conditions such as colitis and atopic dermatitis, and a 2025 review highlights a possible role in supporting immune checkpoint therapies in colorectal cancer, though this remains early-stage and speculative. However, the evidence is notably mixed: at least one large RCT found no improvement in vaccine-induced antibody titers, another found benefits only in a small subgroup of the oldest participants, and a dose-escalation trial in healthy adults found no significant immune effects at any dose tested. Many of the supportive findings come from animal models, cell-line experiments, or studies combining L. paracasei with other probiotic strains, making it difficult to isolate the effects of this organism alone or to draw firm conclusions about its immune benefits in healthy human populations.